Patents by Inventor Shannon Buckley

Shannon Buckley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9241920
    Abstract: The present invention is directed to methods of inhibiting cancer cell proliferation, differentiation and/or survival. These methods involve the administration of Fbw7 E3 ligase inhibitors to inhibit c-Myc ubiquitination in cancerous cell populations, such as leukemic initiating cell populations, that are responsible for disease initiation and progression.
    Type: Grant
    Filed: October 29, 2012
    Date of Patent: January 26, 2016
    Assignee: NEW YORK UNIVERSITY
    Inventors: Iannis Aifantis, Linsey Reavie, Shannon Buckley
  • Publication number: 20140288178
    Abstract: The present invention is directed to methods of inhibiting cancer cell proliferation, differentiation and/or survival. These methods involve the administration of Fbw7 E3 ligase inhibitors to inhibit c-Myc ubiquitination in cancerous cell populations, such as leukemic initiating cell populations, that are responsible for disease initiation and progression.
    Type: Application
    Filed: October 29, 2012
    Publication date: September 25, 2014
    Applicant: NEW YORK UNIVERSITY
    Inventors: Iannis Aifantis, Linsey Reavie, Shannon Buckley
  • Publication number: 20080311084
    Abstract: The present invention relates to MAPCs and progeny derived therefrom to provide lymphohematopoietic cells in a tissue of the lymphohematopoietic system of a subject.
    Type: Application
    Filed: July 29, 2005
    Publication date: December 18, 2008
    Inventors: Catherine M. Verfaillie, Uma Lakshmipathy, Marta Serafini, Shannon Buckley